SCHEMBL15529422

SCHEMBL15529422

CCC(C)(C)C(=O)N1CCC(Oc2ccc(NC(=O)N3CC(c4cccnc4)C3)cc2)C1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15529418 1.00 NAMPT (0.61) NAMPT
SCHEMBL15529376 0.93 NAMPT (0.69) NAMPT
SCHEMBL15528942 0.91 NAMPT (0.61) NAMPT
SCHEMBL15528939 0.91 NAMPT (0.61) NAMPT
SCHEMBL15529222 0.91 NAMPT (0.54) NAMPT
SCHEMBL15528916 0.91 NAMPT (0.54) NAMPT
SCHEMBL15528921 0.91 NAMPT (0.54) NAMPT
SCHEMBL15529766 0.88 NAMPT (0.58) NAMPT
SCHEMBL15529064 0.88 NPC1 (0.56) NAMPT
SCHEMBL15529552 0.87 NAMPT (0.60) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2852585-A1 NAMPT INHIBITORS AbbVie Inc. (US) 2015-04-01 EP claimed
WO-2013170113-A1 NAMPT INHIBITORS ABBVIE INC. (US) 2013-11-14 WO claimed
EP-2852585-A1 NAMPT INHIBITORS AbbVie Inc. (US) 2015-04-01 EP disclosed
WO-2013170113-A1 NAMPT INHIBITORS ABBVIE INC. (US) 2013-11-14 WO disclosed